Kyongbo Pharmaceutical Co Ltd (214390) — Net Asset Quality Index
Kyongbo Pharmaceutical Co Ltd (214390) has a Net Asset Quality Index of 45.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩316.49 Billion minus total liabilities of ₩171.21 Billion yields net assets of ₩145.28 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Kyongbo Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kyongbo Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Kyongbo Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 45.9%, representing net assets of ₩145.28 Billion against total assets of ₩316.49 Billion KRW. Explore Kyongbo Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Kyongbo Pharmaceutical Co Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Kyongbo Pharmaceutical Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Kyongbo Pharmaceutical Co Ltd (214390) market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 51.5% | ₩146.15 Billion | ₩283.89 Billion | ₩137.73 Billion | ▼ -2.7 pp |
| 2023 | 54.2% | ₩144.38 Billion | ₩266.31 Billion | ₩121.92 Billion | ▼ -5.5 pp |
| 2022 | 59.7% | ₩143.70 Billion | ₩240.54 Billion | ₩96.84 Billion | ▼ -1.7 pp |
| 2021 | 61.5% | ₩145.70 Billion | ₩236.98 Billion | ₩91.28 Billion | ▼ -0.1 pp |
| 2020 | 61.6% | ₩156.06 Billion | ₩253.24 Billion | ₩97.18 Billion | ▼ -1.1 pp |
| 2019 | 62.7% | ₩149.16 Billion | ₩237.82 Billion | ₩88.65 Billion | ▼ -4.5 pp |
| 2018 | 67.2% | ₩149.01 Billion | ₩221.62 Billion | ₩72.61 Billion | ▼ -1.8 pp |
| 2017 | 69.1% | ₩141.51 Billion | ₩204.87 Billion | ₩63.36 Billion | ▲ +5.6 pp |
| 2016 | 63.5% | ₩129.40 Billion | ₩203.74 Billion | ₩74.33 Billion | ▲ +0.7 pp |
| 2015 | 62.8% | ₩122.82 Billion | ₩195.49 Billion | ₩72.67 Billion | ▲ +22.2 pp |
| 2014 | 40.7% | ₩68.33 Billion | ₩168.03 Billion | ₩99.70 Billion | — |